This study explored KL‐6 concentrations through the CLEIA method in serum and BAL of patients with various ILDs, showing significant differences of biomarkers concentrations between IPF and other non‐IPF ILDs. This evidence concerns the gene MUC1 and idiopathic pulmonary fibrosis.